Generation Bio (GBIO) Net Income towards Common Stockholders (2022 - 2025)
Historic Net Income towards Common Stockholders for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to -$5.5 million.
- Generation Bio's Net Income towards Common Stockholders rose 6395.22% to -$5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$62.6 million, marking a year-over-year increase of 5788.56%. This contributed to the annual value of -$131.7 million for FY2024, which is 399.33% down from last year.
- Per Generation Bio's latest filing, its Net Income towards Common Stockholders stood at -$5.5 million for Q3 2025, which was up 6395.22% from -$20.9 million recorded in Q2 2025.
- Generation Bio's 5-year Net Income towards Common Stockholders high stood at -$5.5 million for Q3 2025, and its period low was -$74.5 million during Q1 2024.
- Moreover, its 4-year median value for Net Income towards Common Stockholders was -$32.0 million (2022), whereas its average is -$29.8 million.
- In the last 5 years, Generation Bio's Net Income towards Common Stockholders tumbled by 11379.28% in 2024 and then soared by 8014.25% in 2025.
- Over the past 4 years, Generation Bio's Net Income towards Common Stockholders (Quarter) stood at -$34.7 million in 2022, then decreased by 10.76% to -$38.4 million in 2023, then skyrocketed by 44.35% to -$21.4 million in 2024, then surged by 74.18% to -$5.5 million in 2025.
- Its Net Income towards Common Stockholders was -$5.5 million in Q3 2025, compared to -$20.9 million in Q2 2025 and -$14.8 million in Q1 2025.